OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis
Benjamin Ungar, Leore Lavin, Alexandra Golant, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 128, Iss. 6, pp. 734-736
Open Access | Times Cited: 12
Benjamin Ungar, Leore Lavin, Alexandra Golant, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 128, Iss. 6, pp. 734-736
Open Access | Times Cited: 12
Showing 12 citing articles:
Recent developments in the immunopathology of COVID ‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 62
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 62
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology
Phil Lieberman, Derek K. Chu, Tasnuva Ahmed, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 3, pp. 286-294
Open Access | Times Cited: 5
Phil Lieberman, Derek K. Chu, Tasnuva Ahmed, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 3, pp. 286-294
Open Access | Times Cited: 5
Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections
Lauren A. Chang, Michael Schotsaert
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 1
Lauren A. Chang, Michael Schotsaert
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 1
Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
Yin Yao, Ao Huang, Yi‐Ke Deng, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 6, pp. 780-783
Open Access | Times Cited: 8
Yin Yao, Ao Huang, Yi‐Ke Deng, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 6, pp. 780-783
Open Access | Times Cited: 8
Recent developments in the immunopathology of COVID-19
Yadong Gao, Huanping Zhang, Yuanli Sun, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 4
Yadong Gao, Huanping Zhang, Yuanli Sun, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 4
The impact of dupilumab treatment on SARS‐CoV ‐2 T cell responses in atopic dermatitis patients
Benjamin Ungar, Susan Hartzell, Daniel Lozano‐Ojalvo, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 571-574
Open Access | Times Cited: 3
Benjamin Ungar, Susan Hartzell, Daniel Lozano‐Ojalvo, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 571-574
Open Access | Times Cited: 3
Impact of COVID-19 pandemic on adults and children with atopic dermatitis and food allergy: Systematic review
Colver Ken Howe Ne, Noor H. A. Suaini, Win Thu Aung, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100181-100181
Open Access | Times Cited: 1
Colver Ken Howe Ne, Noor H. A. Suaini, Win Thu Aung, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100181-100181
Open Access | Times Cited: 1
A novel protocol for de-isolating moderately and severely immunocompromised COVID-19 patients
Kohei Kamegai, Noriko Iwamoto, Masahiro Ishikane, et al.
Global Health & Medicine (2023) Vol. 5, Iss. 6, pp. 366-371
Open Access | Times Cited: 1
Kohei Kamegai, Noriko Iwamoto, Masahiro Ishikane, et al.
Global Health & Medicine (2023) Vol. 5, Iss. 6, pp. 366-371
Open Access | Times Cited: 1
Letter to the editor submitted in response to ‘Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study’
Maddalena Napolitano, Luca Potestio, Francesca di Vico, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 7, pp. 3066-3067
Closed Access
Maddalena Napolitano, Luca Potestio, Francesca di Vico, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 7, pp. 3066-3067
Closed Access
Management of patients with allergic diseases in the era of COVID-19
Eun Lee
Clinical and Experimental Pediatrics (2022) Vol. 65, Iss. 11, pp. 529-535
Open Access
Eun Lee
Clinical and Experimental Pediatrics (2022) Vol. 65, Iss. 11, pp. 529-535
Open Access
Impact of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the atopic dermatitis serum proteome
Madeline Kim, Benjamin Ungar, Yeriel Estrada, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 3, pp. 355-358
Open Access
Madeline Kim, Benjamin Ungar, Yeriel Estrada, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 3, pp. 355-358
Open Access
